Publikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Sanitaria Valdecilla (23)

2024

  1. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  2. Off-Label Immunosuppressant Drugs in Solid Organ Transplantation

    PHARMACY, Vol. 12, Núm. 1

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Circulating miRNAs signature on breast cancer: the MCC-Spain project

    European Journal of Medical Research, Vol. 28, Núm. 1

2022

  1. Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia

    Schizophrenia Research, Vol. 243, pp. 32-42

  2. High-Sensitivity Troponin T: A Potential Safety Predictive Biomarker for Discharge from the Emergency Department of Patients with Confirmed Influenza

    Journal of Personalized Medicine, Vol. 12, Núm. 4

  3. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  4. Sleep and breast and prostate cancer risk in the MCC-Spain study

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study

    Scientific reports, Vol. 11, Núm. 1, pp. 5375

  2. Predictive value of prolactin in first episode psychosis at ten years follow-up

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 179-180

  3. Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study

    Scientific Reports, Vol. 11, Núm. 1

  4. Tratamientos Psicológicos Empíricamente Apoyados Para Adultos: Una Revisión Selectiva

    Psicothema, Vol. 33, Núm. 2, pp. 188-197

2020

  1. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

    Acta Neuropathologica

  2. Design of polymeric and biocompatible delivery systems by dissolving mesoporous silica templates

    International Journal of Molecular Sciences, Vol. 21, Núm. 24, pp. 1-13

  3. Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients with Inflammatory Bowel Disease: Results from the Eneida Registry

    Inflammatory Bowel Diseases, Vol. 26, Núm. 4, pp. 606-616

  4. Engineering sub-cellular targeting strategies to enhance safe cytosolic silica particle dissolution in cells

    Pharmaceutics, Vol. 12, Núm. 6

  5. Prospective multicentre study of rectal carriage of multidrug-resistant Enterobacteriaceae among health-care workers in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 5, pp. 649.e1-649.e4

  6. Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly

    Cell Metabolism, Vol. 31, Núm. 3, pp. 605-622.e10

2019

  1. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

    Acta Neuropathologica, Vol. 138, Núm. 2, pp. 237-250

  2. Automatic pigmented lesion segmentation through a dermoscopy-guided OCT approach for early diagnosis

    Progress in Biomedical Optics and Imaging - Proceedings of SPIE